Yohei Chiba

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, Rikako Ito, Sho Sato, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Tadahiro Shoji, Naoki Yanagawa, Tsukasa Baba
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system. Japanese journal of clinical oncology 54 (4) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, Rikako Ito, Sho Sato, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Tadahiro Shoji, Naoki Yanagawa, Tsukasa Baba
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system. Japanese journal of clinical oncology (2024)